Abstract:Objective:To evaluate the long-term risk of rebleeding in patients with acute esophageal and gastric variceal bleeding and portal vein thrombosis after endoscopic treatment in liver cirrhosis.Methods:From January to December 2022, 57 patients with acute esophageal and gastric variceal bleeding who were treated by endoscopy in the emergency department of the Zhongshan Hospital affiliated to the Fudan University were included in the study. According to the results of portal vein CT angiography (CTA), the patients were divided into thrombosis group and non thrombosis group. We compared the basic information and endoscopic treatment status of two groups of patients. All patients were followed up until 1 year after endoscopic treatment or April 15, 2023, and re bleeding and survival were recorded during the follow-up period. The influencing factors of rebleeding after 1 year of treatment were analyzed.Results:The patient′s age was (55.9±11.4)years old, mainly male [78.95%(45/57)]. The average time from initial bleeding to endoscopic treatment for all patients was (6.6±2.8)days. There was no statistically significant difference between the two groups in terms of age, sex, combined liver malignancy, Child-pugh score, first bleeding form, ascites, and first laboratory examination results (including hemoglobin, platelet, Prothrombin time, creatinine) (all P>0.05). There was no statistically significant difference in the history of endoscopic treatment, bleeding distance from endoscopic treatment, the proportion of patients with esophageal varices and gastric varices, the proportion of patients with esophageal varices treated with ligation, and the proportion of patients with gastric varices treated with tissue glue between the two groups (all P>0.05). A total of 2 patients died after surgery, and 12 patients experienced rebleeding, including 10 in the thrombotic group and 2 in the non thrombotic group. Kaplan Meier analysis showed that the 1-year rebleeding rate in the thrombotic group was significantly higher than that in the non thrombotic group (59.02% vs 24.71%, RR=6.002, 95% CI: 1.06-34.00, P=0.020 8). Cox multivariate regression analysis suggests that the presence of portal vein thrombosis ( HR=7.669, 95% CI: 1.453-40.472, P=0.016) was an independent risk factor for recurrent bleeding after endoscopic treatment of acute esophageal and gastric variceal bleeding for one year. Conclusions:Portal vein thrombosis in liver cirrhosis increases the risk of recurrent bleeding after endoscopic treatment for acute esophageal and gastric variceal bleeding for one year. For patients with acute Upper gastrointestinal bleeding complicated with portal vein thrombosis, regular endoscopic and ultrasonic follow-up, individualized endoscopic sequential and selective anticoagulation therapy should be carried out.

Influences of etiology and endoscopic appearance on the long-term outcomes of gastric antral vascular ectasia

S1888 Clinical Relevance and Implications of Gastric Antral Vascular Ectasia (GAVE) in Cirrhotic Patients

Recurrent gastric antral vascular ectasia: a single center experience

Gastric Antral Vascular Ectasia (GAVE) a case report, review of the literature and update of techniques

Influence of follow-up treatment compliance on prognosis after endoscopic gastroesophageal varices treatment

Gastric Antral Vascular Ectasia: the Evolution of Therapeutic Modalities

Endoscopic treatment for gastric antral vascular ectasia

Comparing Endoscopic Treatment Modalities for Gastric Antral Vascular Ectasia: Efficacy, Safety, and Outcomes in a Network Meta-analysis

The misclassification of gastric antral vascular ectasia

[Gastric antral vascular ectasia:clinical presentation and therapeutic management]

The classification of gastric antral vascular ectasia in cirrhotic patients by Versatile Intelligent Staining Technology

Gastric Antral Vascular Ectasia: Resolution of Bleeding and Stabilization of Hematocrit Following Orthotopic Liver Transplantation

Portal Vein Thrombosis Can Aggravate Esophageal Variceal Bleeding After Endoscopic Variceal Ligation

Influencing Factors and Efficacy of Endoscopic Tissue Adhesives Injection in Preventing Esophageal Gastric Varices Bleeding

The impact of portal vein thrombosis on the long-term efficacy of endoscopic treatment for acute esophageal and gastric variceal bleeding patients

Upper gastrointestinal bleeding from gastric antral vascular ectasia following cocaine use: case presentation and review of literature

Endoscopic Cyanoacrylate Injection with Lauromacrogol for Gastric Varices: Long-Term Outcomes and Predictors in a Retrospective Cohort Study.

Predictors of early bleeding after endoscopic variceal ligation for esophageal varices: a systematic review and meta-analysis

Diagnosis of gastric antral vascular ectasia by transnasal flexible spectral imaging color enhancement

S2340 Effect of PPI Therapy on EGD-Free Interval in Patients With Gastric Antral Vascular Ectasia

Risk factors for glue extrusion bleeding after endoscopic therapy for esophagogastric variceal bleeding